Only a few days to go: We’re raising £25,000 to keep TheyWorkForYou running and make sure people across the UK can hold their elected representatives to account.

Donate to our crowdfunder


Health written question – answered on 23rd January 2007.

Alert me about debates like this

Photo of John Hemming John Hemming Liberal Democrat, Birmingham, Yardley

To ask the Secretary of State for Health what estimate she has made of the effects on costs to the public purse of prescribing Simvastatin instead of Atorvastatin or other branded statins; and what the timetable is for Simvastatin to be prescribed instead of branded statins.

Photo of Caroline Flint Caroline Flint Minister of State (Department of Health) (Public Health)

The NHS Institute for Innovation and Improvement recently published the "Better Care, Better Value" indicators for the second quarter of this financial year. The statins indicator shows that if every primary care trust (PCT) achieved levels of prescribing of lower cost statins similar to the top quarter of PCTs then £84.7 million could be released for patient care. There are no targets, but we expect PCTs and clinicians to be aware that they can help treat more patients by prescribing one of the lower cost statins where it is clinically appropriate.

Does this answer the above question?

Yes4 people think so

No13 people think not

Would you like to ask a question like this yourself? Use our Freedom of Information site.